[Does percutaneous coronary intervention in non-culprit vessels improve the prognosis of acute myocardial infarction complicated by pump failure?].
Naoyuki Katayama(Mie University), Takashi Honda(Osaka Hospital), Hiroshi Kasanuki(Tokyo Women's Medical University), Kōichi Nakao(Kanazawa Seiryo University), Kenji Horiuchi(Kyoto Medical Center)
PubMed
July 1, 2005
Cited by 7
Related Papers
Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure.
|Circulation|1994|1.3k
JCS 2018 Guideline on Diagnosis and Treatment of Acute Coronary Syndrome
|Circulation Journal|2019|582
Impact of Dual Lipid-Lowering Strategy With Ezetimibe and Atorvastatin on Coronary Plaque Regression in Patients With Percutaneous Coronary Intervention
|Journal of the American College of Cardiology|2015|453
Myosin heavy chain gene expression in human heart failure.
|Journal of Clinical Investigation|1997|422